JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Total Assets
Latest total assets as of September 2025: $53.37 Million USD
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) holds total assets worth $53.37 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Total Assets Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (September 2025)
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total assets of $53.37 Million consist of 82.7% current assets and 17.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.0% |
| Accounts Receivable | $5.91 Million | 11.1% |
| Inventory | $4.92 Million | 9.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.10 Million | 2.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's current assets represent 82.7% of total assets in 2025, a decrease from 83.6% in 2018.
- Cash Position: Cash and equivalents constituted 14.0% of total assets in 2025, up from 4.6% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 1.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 11.1% of total assets.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Total Assets
Key competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares generates 0.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares generates $ 2.23 in net profit.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.86 | 2.50 | 1.93 |
| Quick Ratio | 1.65 | 2.08 | 1.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $20.35 Million | $ 25.66 Million | $ 10.43 Million |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | 16.5% |
| Total Assets | $53.37 Million |
| Market Capitalization | $21.92 Million USD |
Valuation Analysis
Below Book Valuation: The market values JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's assets below their book value (0.41 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's assets grew by 16.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual total assets of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $53.37 Million | +16.52% |
| 2024-09-30 | $45.80 Million | +39.20% |
| 2023-09-30 | $32.90 Million | +57.14% |
| 2022-09-30 | $20.94 Million | -4.39% |
| 2021-09-30 | $21.90 Million | +5.22% |
| 2020-09-30 | $20.82 Million | +2.23% |
| 2019-09-30 | $20.36 Million | +9.01% |
| 2018-09-30 | $18.68 Million | -- |